» Articles » PMID: 12020548

Survival Plots of Time-to-event Outcomes in Clinical Trials: Good Practice and Pitfalls

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2002 May 22
PMID 12020548
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

Survival plots of time-to-event data are a key component for reporting results of many clinical trials (and cohort studies). However, mistakes and distortions often arise in the display and interpretation of survival plots. This article aims to highlight such pitfalls and provide recommendations for future practice. Findings are illustrated by topical examples and also based on a survey of recent clinical trial publications in four major journals. Specific issues are: should plots go up or down (we recommend up), how far in time to extend the plot, showing the extent of follow-up, displaying statistical uncertainty by including SEs or CIS, and exercising caution when interpreting the shape of plots and the time-pattern of treatment difference.

Citing Articles

Risks and rates, and the mathematical link between them.

Hanley J Eur J Epidemiol. 2025; 40(1):1-15.

PMID: 39878848 DOI: 10.1007/s10654-024-01191-9.


Long-term liver outcomes after metabolic surgery in compensated cirrhosis due to metabolic dysfunction-associated steatohepatitis.

Aminian A, Aljabri A, Wang S, Bena J, Allende D, Rosen H Nat Med. 2025; .

PMID: 39870816 DOI: 10.1038/s41591-024-03480-y.


Prognostic value of nighttime blood pressure in patients with chronic kidney disease.

Li J, Wei Q, Li S, Song J, Wang C, Zhang J Hypertens Res. 2025; .

PMID: 39837965 DOI: 10.1038/s41440-024-02080-0.


Prognostic relevance of treatment deviations in children with relapsed acute lymphoblastic leukemia who were treated in the ALL-REZ BFM 2002 study.

Argyriadi E, Steffen I, Chen-Santel C, Lissat A, Attarbaschi A, Bourquin J Leukemia. 2024; 39(2):337-345.

PMID: 39663406 PMC: 11794146. DOI: 10.1038/s41375-024-02474-6.


Macitentan in Pulmonary Arterial Hypertension Due to Congenital Heart Disease (CHD-PAH): Real-World Evidence from the OPUS/OrPHeUS Studies.

Chin K, Channick R, Kim N, Ong R, Turricchia S, Martin N Cardiol Ther. 2024; 13(4):775-796.

PMID: 39585521 PMC: 11607228. DOI: 10.1007/s40119-024-00386-1.